US delays pharma tariffs to push for more drug pricing deals

According to government circles, the new tariffs on pharmaceutical imports into the US announced by US President Donald Trump for October 1 will not be imposed after all. This was announced by a high-ranking government official to the German Press Agency. +Get the most important news from Switzerland in your inbox Instead, tariffs are now being prepared against pharmaceutical companies that do not want to relocate their production to the US or lower prices. No specific reasons for the postponement were given. Last week, President Trump surprised many experts by announcing new tariffs. From October 1, imports of branded and patented medicines into the US were to be subject to a 100% surcharge. Pharmaceutical manufacturers who build a production facility in the US would be able to avoid the tariff. He left the details open. + How pharma became Switzerland’s Achilles heel in the US Swiss pharma invests billions in the US Swiss pharmaceutical companies had already announced investment ... Full story here Are you the author? Previous post See more for 3.) Swissinfo Business and Economy Next post
Tags: Featured,global trade,newsletter